Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jean Bismuth

Vascular Surgery Houston, TX Medical Doctor

NPI 1639330053 CMS profile 164644

6550 Fannin St, Suite 1401, Houston, TX 77030

Open in the dashboard

General payments

$242,792

443 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$138,845 paid to institutions, not to them · program years 2019–2021

Through program year 2025, Jean Bismuth of Houston, TX is reported in the CMS Open Payments database as having received $242,792 across 443 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $138,845 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $45,002 69
2024 General $51,155 81
2023 General $38,004 64
2022 General $27,053 59
2021 General $9,984 42
2020 General $19,963 36
2019 General $51,633 92

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jean Bismuth
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Jean Bismuth were reported at $45,002. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Jean Bismuth Vascular Surgery median Middle half National median
2019 $51,633 $796 $226–$2,363 $163
2020 $19,963 $348 $118–$1,110 $114
2021 $9,984 $471 $158–$1,421 $132
2022 $27,053 $725 $222–$2,183 $149
2023 $38,004 $836 $257–$2,440 $160
2024 $51,155 $909 $252–$2,619 $164
2025 $45,002 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $87,858 157 payments
  2. Penumbra, Inc. $83,023 90 payments
  3. Cook Incorporated $22,290 7 payments
  4. Philips Electronics North America Corporation $19,106 22 payments
  5. Ge Healthcare $13,631 8 payments
  6. Ethicon US, LLC $6,050 3 payments
  7. Cook Medical LLC $4,128 75 payments
  8. Boston Scientific Corporation $2,778 14 payments
  9. Shockwave Medical, Inc $352 4 payments
  10. Medtronic Vascular, Inc. $319 4 payments
  11. Other $3,257 59 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $78,280 25 payments
  2. Honoraria $52,035 8 payments
  3. Consulting Fee $45,916 39 payments
  4. Travel and Lodging $39,340 70 payments
  5. Food and Beverage $24,472 298 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,700 2 payments
  7. Education $50 1 payment
Products named General payments · program years 2019–2025
  1. Indigo System $76,303 74 payments
  2. Conformable TAG Thoracic Endoprosthesis $18,146 4 payments
  3. Zilver PTX $13,915 21 payments
  4. Allia $13,068 2 payments
  5. GORE VIABAHN VBX Balloon Expandable Endo $12,873 31 payments
  6. VIABAHN Endoprosthesis $11,889 17 payments
  7. VIABAHN VBX Balloon Expandable Endoprosthesis $11,329 29 payments
  8. (0073) IGT Enabling functio $10,493 7 payments
  9. Product in Development $8,347 10 payments
  10. EXCLUDER Iliac Branch Endoprosthesis $7,748 2 payments
  11. Other $59,765 263 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

14

Median for Vascular Surgery: 122

Drug cost

$150

Median for Vascular Surgery: $14,135

Branded share of claims

100%

Median for Vascular Surgery: 71%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Clopidogrel Clopidogrel Bisulfate Brand 14 $150

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 3,087 Part D prescribers listed as Vascular Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 111 billing codes

Paid by Medicare

$93,977

Medicare's payments for the services billed

Medicare patients

177

Average age 73

Services billed

442

85 women, 92 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 65%
Arthritis 60%
Chronic kidney disease 49%
COPD 38%
Heart failure 37%
Diabetes 36%
Depression 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

443 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record